[go: up one dir, main page]

PE20061117A1 - DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa - Google Patents

DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa

Info

Publication number
PE20061117A1
PE20061117A1 PE2006000049A PE2006000049A PE20061117A1 PE 20061117 A1 PE20061117 A1 PE 20061117A1 PE 2006000049 A PE2006000049 A PE 2006000049A PE 2006000049 A PE2006000049 A PE 2006000049A PE 20061117 A1 PE20061117 A1 PE 20061117A1
Authority
PE
Peru
Prior art keywords
alkyl
inhibitors
factor viia
preferred
phenylglycinamide
Prior art date
Application number
PE2006000049A
Other languages
English (en)
Inventor
Xiaojun Zhang
Eldon Scott Priestley
Alexandra A Nirschl
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20061117A1 publication Critical patent/PE20061117A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE Y ES A, B, ENTRE OTROS; R1 ES H, F, Cl, ALQUILO C1-C5, ENTRE OTROS; R2 Y R3 SON CADA UNO H, F, Cl, OCF3, CN, ENTRE OTROS; R4 ES H, F, CN, NO2, ALQUILO C1-C6, ENTRE OTROS; W ES NH, O; Z ES DE PREFERENCIA 1-ISOQUINOLIN; A ES UN HETEROCICLO DE 4-8 MIEMBROS, DE PREFERENCIA N-PIRROLIDIN; R8 ES H, CN, TETRAZOLILO, ALQUILO C1-C4 SUSTITUIDO; R9 ES FENILACETAMIDA, 2-ISOPROPILTIOFENIL, 3-NITROFENIL, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: SAL ACIDO TRIFLUOROACETICO DE 2-(1-AMINOSIOQUINOLIN-6-ILAMINO)-2-(3-ETOXI-4-ISOPROPOXIFENIL)-1-(2-FENILPIRROLIDIN-1-IL)ETANONA; SAL ACIDO TRIFLUOROACETICO DE N-(3-((S)-1-((R)-2-(1-AMINOISOQUINOLIN-6-ILAMINO)-2-(3-ETOXI-4-ISOPROPOXIFENIL)ACETIL)PIRROLIDIN-2-IL)FENIL)ACETAMIDA; ENTRE OTROS. DICHOS COMPUESTOS SON INHIBIDORES DE LA SERINA PROTEASA DE LA CASCADA DE COAGULACION, EN PARTICULAR DEL FACTOR VIIa UTILES EN EL TRATAMIENTO DE TRASTORNOS TROMBOEMBOLICOS
PE2006000049A 2005-01-10 2006-01-09 DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa PE20061117A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64275105P 2005-01-10 2005-01-10

Publications (1)

Publication Number Publication Date
PE20061117A1 true PE20061117A1 (es) 2006-10-13

Family

ID=36587246

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000049A PE20061117A1 (es) 2005-01-10 2006-01-09 DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa

Country Status (9)

Country Link
US (1) US7622585B2 (es)
EP (1) EP1856096B1 (es)
AR (1) AR054321A1 (es)
AT (1) ATE479676T1 (es)
DE (1) DE602006016566D1 (es)
ES (1) ES2349428T3 (es)
PE (1) PE20061117A1 (es)
TW (1) TW200637843A (es)
WO (1) WO2006076246A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR051984A1 (es) * 2004-12-08 2007-02-21 Bristol Myers Squibb Co Compuestos heterociclicos como inhibidores del factor viia
WO2007002313A2 (en) * 2005-06-24 2007-01-04 Bristol-Myers Squibb Company Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
TW200745062A (en) * 2005-12-23 2007-12-16 Bristol Myers Squibb Co Macrocyclic factor VIIA inhibitors useful as anticoagulants
WO2007082131A1 (en) * 2006-01-09 2007-07-19 Bristol-Myers Squibb Company Process for the preparation of hydroxy substituted heterocycles
JP2009539873A (ja) 2006-06-08 2009-11-19 ブリストル−マイヤーズ スクイブ カンパニー 抗凝固剤として有用な第ＶＩＩａ因子インヒビターとしての２−アミノカルボニルフェニルアミノ−２−フェニルアセトアミド類
EP2099783A1 (en) * 2006-12-20 2009-09-16 Brystol-Myers Squibb Company Bicyclic lactam factor viia inhibitors useful as anticoagulants
PE20081775A1 (es) * 2006-12-20 2008-12-18 Bristol Myers Squibb Co Compuestos macrociclicos como inhibidores del factor viia
US20110160232A1 (en) * 2007-10-04 2011-06-30 Pingda Ren Certain chemical entities and therapeutic uses thereof
US8637542B2 (en) 2008-03-14 2014-01-28 Intellikine, Inc. Kinase inhibitors and methods of use
WO2009114874A2 (en) 2008-03-14 2009-09-17 Intellikine, Inc. Benzothiazole kinase inhibitors and methods of use
AU2009268611B2 (en) 2008-07-08 2015-04-09 Intellikine, Llc Kinase inhibitors and methods of use
EP2149565A1 (de) 2008-07-24 2010-02-03 Bayer Schering Pharma AG Sulfonsubstituierte Chinazolinderivate als Immunmodulatoren zur Behandlung von enzündlichen und allergischen Erkrankungen
JP5417860B2 (ja) * 2008-08-26 2014-02-19 住友化学株式会社 α−ヒドロキシエステル類の製造方法
US8476282B2 (en) 2008-11-03 2013-07-02 Intellikine Llc Benzoxazole kinase inhibitors and methods of use
CA2812608C (en) 2010-10-06 2020-07-14 Glaxosmithkline Llc Benzimidazole derivatives as pi3 kinase inhibitors
CA2828483A1 (en) 2011-02-23 2012-11-01 Intellikine, Llc Combination of kinase inhibitors and uses thereof
WO2015123091A1 (en) 2014-02-11 2015-08-20 Merck Sharp & Dohme Corp. Factor xia inhibitors
EP3104703B1 (en) 2014-02-11 2020-11-18 Merck Sharp & Dohme Corp. Factor xia inhibitors
US10093683B2 (en) 2014-04-22 2018-10-09 Merck Sharp & Dohme Corp. Factor XIa inhibitors
US9868727B2 (en) 2014-07-28 2018-01-16 Merck Sharp & Dohme Corp. Factor XIa inhibitors
MA43128A (fr) 2015-10-29 2018-09-05 Merck Sharp & Dohme Inhibiteurs du facteur xia
WO2017074833A1 (en) 2015-10-29 2017-05-04 Merck Sharp & Dohme Corp. Macrocyclic spirocarbamate derivatives as factor xia inhibitors, pharmaceutically acceptable compositions and their use
WO2017158147A1 (en) 2016-03-18 2017-09-21 Savira Pharmaceuticals Gmbh Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
US10143681B2 (en) 2016-08-22 2018-12-04 Merck Sharp & Dohme Corp. Factor XIa inhibitors
CN112225647A (zh) * 2020-10-14 2021-01-15 河南中医药大学 一种合成5-溴-2-甲氧基苯酚的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023236A (en) 1988-04-07 1991-06-11 Corvas, Inc. Factor VII/VIIA active site inhibitors
FR2667864B2 (fr) 1990-03-07 1994-08-05 Rhone Poulenc Sante Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant.
US5843442A (en) 1990-10-22 1998-12-01 Corvas International, Inc. Blood coagulation protein antagonists and uses therefor
US5563127A (en) 1993-03-24 1996-10-08 The Dupont Merck Pharmaceutical Company Boronic acid and ester inhibitors of thrombin
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5866542A (en) 1994-10-18 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
AU6944696A (en) 1995-09-14 1997-04-01 Shionogi & Co., Ltd. Novel phenylacetic acid derivatives and medicinal composition containing the same
IL123986A (en) 1997-04-24 2011-10-31 Organon Nv Medicinal compounds
DE59808751D1 (de) 1997-12-04 2003-07-24 Hoffmann La Roche N-(4-carbamimido-phenyl)-glycinamidderivate
US6358960B1 (en) 1998-02-17 2002-03-19 Ono Pharmaceutical Co., Ltd. Amidino derivatives and drugs containing the same as the active ingredient
US6335324B1 (en) 1998-06-25 2002-01-01 Bristol-Myers Squibb Co. Beta lactam compounds and their use as inhibitors of tryptase
TR200101744T2 (tr) 1998-12-14 2001-12-21 F. Hoffmann-La Roche Ag Fenilglisin türevleri.
EP1144373B1 (en) 1999-01-13 2005-10-19 Genentech, Inc. Serine protease inhibitors
CA2394639A1 (en) 1999-12-15 2001-06-21 Danny Peter Claude Mcgee Salicylamides as serine protease and factor xa inhibitors
WO2001055123A1 (fr) 2000-01-26 2001-08-02 Ono Pharmaceutical Co., Ltd. Composes cycliques a 5 chainons, contenant de l'azote, et medicaments contenant ces composes comme ingredients actifs
US6548694B2 (en) 2000-05-23 2003-04-15 Hoffman-La Roche Inc. N-(4-carbamimidoyl-phenyl)-glycine derivatives
DE10027025A1 (de) * 2000-05-31 2001-12-06 Merck Patent Gmbh Clycinamide
WO2002009688A1 (en) 2000-08-02 2002-02-07 Smithkline Beecham Corporation Fatty acid synthase inhibitors
DK1383731T3 (da) 2000-10-20 2009-12-07 Biocryst Pharm Inc Biarylforbindelser som serinproteaseinhibitorer
CA2428191A1 (en) 2000-11-07 2002-05-30 Bristol-Myers Squibb Company Acid derivatives useful as serine protease inhibitors
PT1383731E (pt) 2001-04-06 2009-11-03 Biocryst Pharm Inc Compostos de biarilo como inibidores de serina-protease
DE10139060A1 (de) 2001-08-08 2003-02-20 Merck Patent Gmbh Phenylderivate
US6642386B2 (en) 2002-02-06 2003-11-04 Hoffmann-La Roche Inc. N-(4-carbamimidoyl-phenyl)-glycine derivatives
DE10214832A1 (de) 2002-04-04 2003-10-16 Merck Patent Gmbh Phenylderivate 4
EP1594505A4 (en) 2003-02-11 2008-08-13 Bristol Myers Squibb Co PHENYLGLYCIN DERIVATIVES USEFUL AS SERINE PROTEASE INHIBITORS
WO2004072102A2 (en) 2003-02-11 2004-08-26 Bristol-Myers Squibb Company Benzene acetamide compounds useful as serine protease inhibitors
DE10310278A1 (de) * 2003-03-10 2004-09-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue aromatische Bicyclen, deren Herstellung und deren Verwendung als Arzneimittel
US20050107409A1 (en) 2003-03-10 2005-05-19 Boehringer Ingelheim International Gmbh Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions
US7309708B2 (en) 2003-11-20 2007-12-18 Birstol-Myers Squibb Company Hepatitis C virus inhibitors
AR051984A1 (es) 2004-12-08 2007-02-21 Bristol Myers Squibb Co Compuestos heterociclicos como inhibidores del factor viia
WO2007002313A2 (en) 2005-06-24 2007-01-04 Bristol-Myers Squibb Company Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants

Also Published As

Publication number Publication date
EP1856096B1 (en) 2010-09-01
ES2349428T3 (es) 2011-01-03
EP1856096A2 (en) 2007-11-21
WO2006076246A3 (en) 2006-09-28
AR054321A1 (es) 2007-06-20
US20060166997A1 (en) 2006-07-27
WO2006076246A2 (en) 2006-07-20
US7622585B2 (en) 2009-11-24
DE602006016566D1 (de) 2010-10-14
ATE479676T1 (de) 2010-09-15
TW200637843A (en) 2006-11-01

Similar Documents

Publication Publication Date Title
PE20061117A1 (es) DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa
PE20120345A1 (es) Derivados de 2-(1h-pirrolo[2,3-b]piridin-5-iloxi)-n-fenilsulfonilbenzamida como inhibidores de proteinas anti-apoptoticas
AR072098A1 (es) Derivados de pirrolidina como inhibidores de metap-2
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
PE20081385A1 (es) Derivados de nicotinamida
PE20090434A1 (es) Derivados de sulfonil amida como inhibidores de quinasas
PE20090509A1 (es) El uso de derivados de benzamida para el tratamiento de transtornos del snc
RS53688B1 (en) 1,2,5-OXADIAZOLES AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
PE20121157A1 (es) Compuestos heterociclicos como inhibidores de proteasas serinas
PE20070189A1 (es) COMPUESTO DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA MODULACION DE LA ß-SECRETASA
AR078944A1 (es) Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa
PE20091201A1 (es) AMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON (Btk)
PE20070593A1 (es) Compuestos pirrolopirimidina como inhibidores de syk
PE20071132A1 (es) Compuestos macrociclicos como inhibidores del factor viia
AR050941A1 (es) SERINAMIDAS SUSTITUIDAS POR BENZOILO, PROCESOS PARA SU PREPARACION, INTERMEDIARIOS PARA SU SINTESIS, USO DE LAS MISMAS EN LA FABRICACIoN DE PRODUCTOS FITOSANITARIOS Y PROCEDIMEITNSO PARA CONTROLAR EL CRECIMIENTO DE PLANTAS INDESEADAS
PE20061198A1 (es) Derivados de pirazol como inhibidores de cdk y gsk
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
PE20080856A1 (es) Inhibidores de metaloproteasas de matriz
EA201170130A1 (ru) Бензоксазины, бензотиазины и родственные соединения, обладающие ингибирующей nos активностью
PE20080061A1 (es) Compuestos derivados de amida como inhibidores de los canales de potasio task-1 y task-3
CO6170361A2 (es) Composiciones y metodos para modular receptores de c-kit y pdgfr
PE20050691A1 (es) Proceso para preparar carboxamidas 2-aminotiazol-5-aromaticas como inhibidores de la cinasa
PE20071322A1 (es) Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer

Legal Events

Date Code Title Description
FC Refusal